Douglas J. Dorahy

1.1k total citations
21 papers, 911 citations indexed

About

Douglas J. Dorahy is a scholar working on Hematology, Immunology and Allergy and Molecular Biology. According to data from OpenAlex, Douglas J. Dorahy has authored 21 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 7 papers in Immunology and Allergy and 6 papers in Molecular Biology. Recurrent topics in Douglas J. Dorahy's work include Platelet Disorders and Treatments (7 papers), Cell Adhesion Molecules Research (7 papers) and Cystic Fibrosis Research Advances (5 papers). Douglas J. Dorahy is often cited by papers focused on Platelet Disorders and Treatments (7 papers), Cell Adhesion Molecules Research (7 papers) and Cystic Fibrosis Research Advances (5 papers). Douglas J. Dorahy collaborates with scholars based in Australia, United States and United Kingdom. Douglas J. Dorahy's co-authors include Gordon F. Burns, Darren R. Shafren, Richard D. Barry, Cliff Meldrum, Rick F. Thorne, Lisa F. Lincz, Michael Agrez, Rodney J. Scott, Jun Niu and John V. Fecondo and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Oncogene.

In The Last Decade

Douglas J. Dorahy

21 papers receiving 898 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas J. Dorahy Australia	17	325	224	189	175	173	21	911
Bruce Fowler United States	12	428 1.3×	117 0.5×	68 0.4×	25 0.1×	172 1.0×	12	902
Sophie Allart France	18	312 1.0×	45 0.2×	84 0.4×	49 0.3×	272 1.6×	31	1.0k
P. Wijngaard Netherlands	11	264 0.8×	147 0.7×	30 0.2×	78 0.4×	387 2.2×	26	943
Cecilia Soh United Kingdom	12	416 1.3×	37 0.2×	291 1.5×	55 0.3×	254 1.5×	16	840
Daniella M. Mizurini Brazil	16	282 0.9×	68 0.3×	88 0.5×	50 0.3×	410 2.4×	22	842
Jonathan G. Lieber United States	11	477 1.5×	80 0.4×	80 0.4×	24 0.1×	469 2.7×	12	1.1k
M C Hu United States	11	432 1.3×	144 0.6×	108 0.6×	35 0.2×	315 1.8×	12	810
Sadayoshi Sekiguchi Japan	15	150 0.5×	35 0.2×	78 0.4×	61 0.3×	164 0.9×	75	745
Elizabeth M. Williamson United Kingdom	11	905 2.8×	103 0.5×	53 0.3×	96 0.5×	723 4.2×	13	1.8k
Tomoko Taguchi Japan	18	489 1.5×	42 0.2×	86 0.5×	20 0.1×	387 2.2×	39	1.1k

Countries citing papers authored by Douglas J. Dorahy

Since Specialization

Citations

This map shows the geographic impact of Douglas J. Dorahy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas J. Dorahy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas J. Dorahy more than expected).

Fields of papers citing papers by Douglas J. Dorahy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas J. Dorahy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas J. Dorahy. The network helps show where Douglas J. Dorahy may publish in the future.

Co-authorship network of co-authors of Douglas J. Dorahy

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas J. Dorahy. A scholar is included among the top collaborators of Douglas J. Dorahy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas J. Dorahy. Douglas J. Dorahy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barker, Daniel, Lucy Burr, Hugh Greville, et al.. (2019). Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease. Journal of Cystic Fibrosis. 19(3). 415–420. 14 indexed citations

Wark, Peter, et al.. (2019). Lumacaftor/ Ivacaftor improves exercise tolerance in patients with Cystic Fibrosis and severe airflow obstruction. BMC Pulmonary Medicine. 19(1). 106–106. 31 indexed citations

Dorahy, Douglas J., Lucy Burr, Hugh Greville, et al.. (2019). A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis. OA2126–OA2126. 1 indexed citations

Dentice, Ruth, Mark R. Elkins, Peter G. Middleton, et al.. (2016). A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis. Thorax. 71(2). 141–147. 33 indexed citations

Dentice, Ruth, Mark R. Elkins, Paul M Middleton, et al.. (2013). WS19.4 A randomised controlled trial of the effect of hypertonic saline (HS) inhalation on exacerbation resolution, hospital length of stay and time to relapse in adults with cystic fibrosis. Journal of Cystic Fibrosis. 12. S38–S38. 5 indexed citations

Agrez, Michael, Madhu B. Garg, Douglas J. Dorahy, & Stephen P. Ackland. (2011). Synergistic Anti-Tumor Effect of Cisplatin When Combined with an Anti-Src Kinase Integrin-Based Peptide. Journal of Cancer Therapy. 2(3). 295–301. 5 indexed citations

Niu, Jun, Douglas J. Dorahy, Xinhua Gu, et al.. (2002). Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the β6 integrin subunit. International Journal of Cancer. 99(4). 529–537. 41 indexed citations

Ahmed, Nuzhat, Jun Niu, Douglas J. Dorahy, et al.. (2002). Direct integrin αvβ6-ERK binding: implications for tumour growth. Oncogene. 21(9). 1370–1380. 86 indexed citations

Gu, Xueping, Jun Niu, Douglas J. Dorahy, Rodney J. Scott, & Michael Agrez. (2002). Integrin αvβ6-associated ERK2 mediates MMP-9 secretion in colon cancer cells. British Journal of Cancer. 87(3). 348–351. 42 indexed citations

10.

Shafren, Darren R., Richard D. Barry, Douglas J. Dorahy, & Rick F. Thorne. (2000). Cytoplasmic interactions between decay-accelerating factor and intercellular adhesion molecule-1 are not required for coxsackievirus A21 cell infection. Journal of General Virology. 81(4). 889–894. 18 indexed citations

11.

Gruarin, Paola, Rick F. Thorne, Douglas J. Dorahy, et al.. (2000). CD36 Is a Ditopic Glycoprotein with the N-Terminal Domain Implicated in Intracellular Transport. Biochemical and Biophysical Research Communications. 275(2). 446–454. 40 indexed citations

12.

Shafren, Darren R., Douglas J. Dorahy, Rick F. Thorne, et al.. (1998). Antibody Binding to Individual Short Consensus Repeats of Decay-Accelerating Factor Enhances Enterovirus Cell Attachment and Infectivity. The Journal of Immunology. 160(5). 2318–2323. 20 indexed citations

13.

Dorahy, Douglas J. & Gordon F. Burns. (1998). Active Lyn protein tyrosine kinase is selectively enriched within membrane microdomains of resting platelets. Biochemical Journal. 333(2). 373–379. 37 indexed citations

14.

Dorahy, Douglas J., Rick F. Thorne, John V. Fecondo, & Gordon F. Burns. (1997). Stimulation of Platelet Activation and Aggregation by a Carboxyl-terminal Peptide from Thrombospondin Binding to the Integrin-associated Protein Receptor. Journal of Biological Chemistry. 272(2). 1323–1330. 64 indexed citations

15.

Thorne, Rick F., Cliff Meldrum, Simon J. Harris, et al.. (1997). CD36 Forms Covalently Associated Dimers and Multimers in Platelets and Transfected COS-7 Cells. Biochemical and Biophysical Research Communications. 240(3). 812–818. 36 indexed citations

16.

Shafren, Darren R., et al.. (1997). Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. Journal of Virology. 71(6). 4736–4743. 187 indexed citations

17.

Sherrington, Paul D., Judith L. Scott, Boquan Jin, et al.. (1997). TLiSA1 (PTA1) Activation Antigen Implicated in T Cell Differentiation and Platelet Activation Is a Member of the Immunoglobulin Superfamily Exhibiting Distinctive Regulation of Expression. Journal of Biological Chemistry. 272(35). 21735–21744. 34 indexed citations

18.

Dorahy, Douglas J., Michael C. Berndt, Darren R. Shafren, & Gordon F. Burns. (1996). CD36 Is Spatially Associated with Glycoprotein IIb-IIIa (αIIbβ3) on the Surface of Resting Platelets. Biochemical and Biophysical Research Communications. 218(2). 575–581. 18 indexed citations

19.

Dorahy, Douglas J., Lisa F. Lincz, Cliff Meldrum, & Gordon F. Burns. (1996). Biochemical isolation of a membrane microdomain from resting platelets highly enriched in the plasma membrane glycoprotein CD36. Biochemical Journal. 319(1). 67–72. 113 indexed citations

20.

Dorahy, Douglas J., MC Berndt, & Gordon F. Burns. (1995). Capture by chemical crosslinkers provides evidence that integrin α IIb β 3 forms a complex with protein tyrosine kinases in intact platelets. Biochemical Journal. 309(2). 481–490. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact